Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 1/20 | 0.48 |
| ▸ | CPB2 | Q96IY4 | 6/20 | 0.45 |
| ▸ | GNPAT | O15228 | 1/20 | 0.43 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.43 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.43 |
| ▸ | LNPEP | Q9UIQ6 | 1/20 | 0.43 |
| ▸ | ENPEP | Q07075 | 5/20 | 0.41 |
| ▸ | GSR | P00390 | 1/20 | 0.41 |
| ▸ | BACE1 | P56817 | 2/20 | 0.40 |
| ▸ | CTSD | P07339 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29877218 | 0.93 | FNTA (0.44) | FOLH1CPB2GNPATENPEP | |
| SCHEMBL30242247 | 0.91 | GNPAT (0.49) | FOLH1CPB2GNPATENPEPBACE1 | |
| SCHEMBL4270981 | 0.91 | FOLH1 (0.48) | FOLH1CPB2ERAP2ERAP1LNPEP | |
| SCHEMBL4270994 | 0.91 | FOLH1 (0.48) | FOLH1CPB2ERAP2ERAP1LNPEP | |
| SCHEMBL29706243 | 0.90 | ERAP2 (0.53) | FOLH1CPB2ERAP2ERAP1LNPEP | |
| SCHEMBL31110645 | 0.90 | ENPEP (0.46) | ENPEPGSRBACE1 | |
| SCHEMBL30436412 | 0.90 | FOLH1 (0.47) | FOLH1CPB2ERAP2ERAP1LNPEP | |
| SCHEMBL30436675 | 0.90 | FOLH1 (0.47) | FOLH1CPB2ERAP2ERAP1LNPEP | |
| SCHEMBL30436842 | 0.90 | FOLH1 (0.47) | FOLH1CPB2ERAP2ERAP1LNPEP | |
| SCHEMBL30601852 | 0.89 | FOLH1 (0.43) | FOLH1CPB2GNPATERAP2ERAP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4709425-A1 | LINKER COMPOUNDS AND LIGAND-DRUG CONJUGATES, PREPARATION METHODS AND USES THEREOF | Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (CN) | 2026-03-18 | — | — | EP | claimed |
| WO-2024235105-A1 | LINKER COMPOUNDS AND LIGAND-DRUG CONJUGATES, PREPARATION METHODS AND USES THEREOF | BIOCYTOGEN PHARMACEUTICALS (BEIJING) CO., LTD. (CN) | 2024-11-21 | — | — | WO | claimed |
| EP-4709425-A1 | LINKER COMPOUNDS AND LIGAND-DRUG CONJUGATES, PREPARATION METHODS AND USES THEREOF | Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (CN) | 2026-03-18 | — | — | EP | disclosed |
| WO-2024235105-A1 | LINKER COMPOUNDS AND LIGAND-DRUG CONJUGATES, PREPARATION METHODS AND USES THEREOF | BIOCYTOGEN PHARMACEUTICALS (BEIJING) CO., LTD. (CN) | 2024-11-21 | — | — | WO | disclosed |